Literature DB >> 2615350

Regulation of progesterone receptor mRNA by oestradiol and antioestrogens in breast cancer cell lines.

F E May1, M D Johnson, L R Wiseman, A E Wakeling, P Kastner, B R Westley.   

Abstract

The induction of progesterone receptor mRNA by oestradiol and antioestrogens has been characterised in the MCF-7 breast cancer cell line. Progesterone receptor mRNA was induced more than 100-fold by oestradiol. The induction was half-maximal in the presence of 10(-10) M oestradiol and maximum levels were reached after 24 h treatment. Progesterone receptor mRNA was induced to 10% of the oestrogen-induced level by tamoxifen and its metabolite 4'-hydroxytamoxifen. The increase was half-maximal in the presence of 5 X 10(-8) M tamoxifen or 5 X 10(-10) M 4'-hydroxytamoxifen. In contrast, neither the benzothiophene antioestrogen LY117018 nor the 7 alpha-alkyl steroidal antioestrogen ICI 164,384 had any effect on progesterone receptor mRNA. The progesterone receptor mRNA was also induced by oestrogen in a T47D subline and in two other oestrogen-responsive breast cancer cell lines (ZR-75, EFM-19). Tamoxifen was a partial oestrogen for progesterone receptor mRNA induction in each of these cell lines. The large induction of the progesterone receptor mRNA by oestrogen in all 4 breast cancer cell lines supports the contention that the progesterone receptor may be a good predictive marker of hormonal response in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2615350     DOI: 10.1016/0022-4731(89)90406-8

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  19 in total

1.  Effects of antioestrogens on the DNA binding activity of oestrogen receptors in vitro.

Authors:  N D Arbuckle; S Dauvois; M G Parker
Journal:  Nucleic Acids Res       Date:  1992-08-11       Impact factor: 16.971

2.  Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover.

Authors:  S Dauvois; P S Danielian; R White; M G Parker
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Differential screening and suppression subtractive hybridization identified genes differentially expressed in an estrogen receptor-positive breast carcinoma cell line.

Authors:  W W Kuang; D A Thompson; R V Hoch; R J Weigel
Journal:  Nucleic Acids Res       Date:  1998-02-15       Impact factor: 16.971

4.  Pharmacological relevance of endoxifen in a laboratory simulation of breast cancer in postmenopausal patients.

Authors:  Philipp Y Maximov; Russell E McDaniel; Daphne J Fernandes; Puspanjali Bhatta; Valeriy R Korostyshevskiy; Ramona F Curpan; V Craig Jordan
Journal:  J Natl Cancer Inst       Date:  2014-09-24       Impact factor: 13.506

5.  RCL2, a new fixative, preserves morphology and nucleic acid integrity in paraffin-embedded breast carcinoma and microdissected breast tumor cells.

Authors:  Christophe Delfour; Pascal Roger; Caroline Bret; Marie-Laurence Berthe; Philippe Rochaix; Nicolas Kalfa; Pierre Raynaud; Frédéric Bibeau; Thierry Maudelonde; Nathalie Boulle
Journal:  J Mol Diagn       Date:  2006-05       Impact factor: 5.568

6.  Sex hormone-receptor-negative tumors have a higher proliferative activity than sex hormone-receptor-positive tumors in human adenocarcinomas of the gastrointestinal tract.

Authors:  D Korenaga; H Orita; T Okuyama; J Kinoshita; S Maekawa; T Ikeda; K Sugimachi
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

7.  Early histone modifications in the ventromedial hypothalamus and preoptic area following oestradiol administration.

Authors:  K Gagnidze; Z M Weil; L C Faustino; S M Schaafsma; D W Pfaff
Journal:  J Neuroendocrinol       Date:  2013-10       Impact factor: 3.627

8.  Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility.

Authors:  T I Andersen; K R Heimdal; M Skrede; K Tveit; K Berg; A L Børresen
Journal:  Hum Genet       Date:  1994-12       Impact factor: 4.132

9.  Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors.

Authors:  S Singh; M C Sheppard; M J Langman
Journal:  Gut       Date:  1993-05       Impact factor: 23.059

Review 10.  The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review.

Authors:  John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2020-02-22       Impact factor: 2.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.